| European Case Law Identifier: | ECLI:EP:BA:2004:T091801.20041006 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 06 October 2004 | ||||||||
| Case number: | T 0918/01 | ||||||||
| Application number: | 93904830.2 | ||||||||
| IPC class: | A61K 39/395 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Treatment for inflammatory bowel disease | ||||||||
| Applicant name: | BIOGEN, INC. | ||||||||
| Opponent name: | Neumann Lydia Ellen Celltech Therapeutics Ltd. |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main and first auxiliary request - inventive step (no) Second auxiliary request - not admissible |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010918eu1.html
Date retrieved: 17 May 2021
